AUG 10, 2026 · PHASE EARLY PHASE 1 TRIALVyvanse in Children Aged 6 to 12 YearsClinicalTrials.govEarly-phase uncontrolled trial with small sample (n=44) examining lisdexamfetamine for childhood obesity; no results reported in registry record.PreliminaryNCT05416125University of MinnesotaLifestyle therapyReportedPlanned enrollment44Primary endpointPercent change in Body Mass IndexFollow-up duration24 weeks